Trial intelligence / Profile preview

Fluticasone Furoate Nasal Spray for Allergic Rhinitis in Chinese Patients

NCT01231464Phase 3Completed

Sponsor
GSK
Start
Sep 2009
Primary completion
May 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone in allergic rhinitis (AR), sponsored by GSK. Started Sep 2009; status: completed.

02

Drugs

fluticasone
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT01231464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01231464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call